Docteur Suzanne VERCHEVAL Psychiatrie
0831.599.212 · rovalta.com · 27/09/2026
Docteur Suzanne VERCHEVAL Psychiatrie
Company — Normal situation.
Financial year 2025 · Closed on 30/06/2025
Overview
Identity
Source · BCE/KBODocteur Suzanne VERCHEVAL Psychiatrie is a company registered in Belgium.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0831.599.212
- Legal form
- Private limited company
- Contributed capital
- 18 600,00 €
- Latest accounts
- 30/06/2025
Joint committees (1)
- 330
Financials
Source · NBB, 15 filingsTrend over 15 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 160,7 k € | +22.5% | 131,2 k € | +129% | 57,3 k € | -38.4% | 93 k € | -17.4% | 112,5 k € |
| EBITDA | 156,3 k € | +26.0% | 124 k € | +159% | 47,8 k € | -46.2% | 88,9 k € | -3.1% | 91,8 k € |
| Operating result | 114 k € | +42.1% | 80,3 k € | +897% | 8 k € | -78.3% | 37 k € | -16.5% | 44,4 k € |
| Net result | 70,2 k € | +40.8% | 49,8 k € | +1375% | -3,9 k € | -117% | 22,7 k € | -14.1% | 26,5 k € |
| Balance sheet | |||||||||
| Equity | 200 k € | +38.9% | 144,1 k € | +13.9% | 126,4 k € | -3.0% | 130,3 k € | -0.1% | 130,5 k € |
| Total assets | 368,4 k € | -2.0% | 376 k € | -0.1% | 376,5 k € | -6.8% | 404,1 k € | +12.6% | 358,8 k € |
| Cash | 16,6 k € | -20.9% | 20,9 k € | +106% | 10,2 k € | -89.9% | 100,7 k € | +54.6% | 65,1 k € |
| Debts | 168,2 k € | -27.4% | 231,8 k € | -7.3% | 250 k € | -8.7% | 273,7 k € | +19.9% | 228,2 k € |
Board of directors
Source · NBB, accounts to 30/06/20251 active · 1 ended
Active mandates
| Director | Function | Mandate |
|---|---|---|
Suzanne VERCHEVAL | Director | since 30/11/2010 |
Ended mandates
| Director | Function | Mandate |
|---|---|---|
Suzanne VERCHEVAL | Manager | since 30/11/2010 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/07/2024 | 01/07/2023 | 01/07/2022 | 01/07/2021 | 01/07/2020 | 01/07/2019 |
| Closing of the financial year | 30/06/2025 | 30/06/2024 | 30/06/2023 | 30/06/2022 | 30/06/2021 | 30/06/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 11/12/2025 | 04/02/2025 | 31/01/2024 | 31/01/2023 | 31/01/2022 | 18/02/2021 |
| General meeting | 13/11/2025 | 23/12/2024 | 23/12/2023 | 26/12/2022 | 06/12/2021 | 07/12/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 15 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 30/06/2025 | 13/11/2025 | 11/12/2025 | French | |
| Micro model | 30/06/2024 | 23/12/2024 | 04/02/2025 | French | |
| Micro model | 30/06/2023 | 23/12/2023 | 31/01/2024 | French | |
| Micro model | 30/06/2022 | 26/12/2022 | 31/01/2023 | French | |
| Micro model | 30/06/2021 | 06/12/2021 | 31/01/2022 | French | |
| Micro model | 30/06/2020 | 07/12/2020 | 18/02/2021 | French | |
| Micro model | 30/06/2019 | 02/12/2019 | 15/01/2020 | French | |
| Micro model | 30/06/2018 | 03/12/2018 | 14/01/2019 | French | |
| Micro model | 30/06/2017 | 09/01/2018 | 10/01/2018 | French | |
| Abridged model | 30/06/2016 | 05/12/2016 | 04/01/2017 | French | |
| Abridged model | 30/06/2015 | 07/12/2015 | 14/01/2016 | French | |
| Abridged model | 30/06/2014 | 01/12/2014 | 15/12/2014 | French | |
| Abridged model | 30/06/2013 | 02/12/2013 | 20/12/2013 | French | |
| Abridged model | 30/06/2012 | 03/12/2012 | 26/12/2012 | French | |
| Abridged model | 30/06/2011 | 05/12/2011 | 28/12/2011 | French |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 30/06/20251 active · 1 ended
Active mandates
| Director | Function | Mandate |
|---|---|---|
Suzanne VERCHEVAL | Director | since 30/11/2010 |
Ended mandates
| Director | Function | Mandate |
|---|---|---|
Suzanne VERCHEVAL | Manager | since 30/11/2010 |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Restructuring23/02/2026FUSION PAR ABSORPTION - DECISION DE FUSION DE LA SRL “BIOCLIN
- Restructuring04/12/2025Projet de fusion par absorption
- Mandates11/05/2023STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE - DEMISSIONS, NOMINATIONS
- Mandates19/04/2023DEMISSIONS, NOMINATIONS
- Mandates19/04/2023DEMISSIONS, NOMINATIONS
- Other14/12/2010RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202570,2 k €↑
- 2024Annual accounts 202449,8 k €↑
- 2023Annual accounts 2023-3,9 k €↓
- 2022Annual accounts 202222,7 k €↓
- 2021Annual accounts 202126,5 k €↑
- 2020Annual accounts 202025,4 k €↑
- 2019Annual accounts 20198,6 k €↓
- 2018Annual accounts 201817,7 k €↓
- 2017Annual accounts 201722,5 k €↓
- 2016Annual accounts 201632,2 k €↑
- 2015Annual accounts 201516,9 k €↑
- 2014Annual accounts 20144,5 k €↓
- 2013Annual accounts 201315,1 k €↓
- 2012Annual accounts 201215,6 k €↓
- 2011Annual accounts 201120,8 k €